Paris network tracks rare Flesh-Eating infections to improve survival
NCT ID NCT07417982
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 1,000 patients with rare, life-threatening skin and soft tissue infections who are treated through a special care network in the greater Paris area. Researchers will track survival rates, long-term complications, and quality of life to understand what factors affect outcomes. The goal is to learn how to improve care for these serious infections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NECROTIZING SOFT-TISSUE INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Henri Mondor, 1 rue Gustave Eiffel,
Créteil, Île-de-France Region, 94000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.